Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT07188532
Recruiting
Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Not applicable · United States · 2 sites
Registry update: 6 Oct 2026
NCT07089992
Recruiting
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Phase 2 · United States · 7 sites
Registry update: 28 Jul 2026
NCT07197554
Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Phase 1 · United States · 6 sites
Registry update: 27 Oct 2026
NCT07148193
Recruiting
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Not applicable · Germany · 5 sites
Registry update: 8 Dec 2025
NCT07864870
Recruiting
Sarcoma Care Adherence and Survival in Strasbourg
Not applicable · France · 1 site
Registry update: 8 Oct 2026
NCT07223047
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Phase 1/2 · Canada, Spain, United States · 8 sites
Registry update: 28 May 2026
NCT07261631
Recruiting
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Phase 1 · Canada, Germany, Denmark, France, Israel, Singapore, United States · 8 sites
Registry update: 9 Oct 2026
NCT07328425
Recruiting
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Phase 2 · Spain, Italy · 11 sites
Registry update: 3 Nov 2026
NCT07229313
Recruiting
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · Australia, United States · 7 sites
Registry update: 24 Sept 2026
NCT07244835
Recruiting
A Study of DEG6498 in Participants With Solid Tumors
Phase 1 · China · 3 sites
Registry update: 30 Jun 2026
NCT07156565
Recruiting
Actinium Therapy for Late-stage Aggressive Sarcomas
Phase 1 · Canada, United States · 6 sites
Registry update: 28 Aug 2026
NCT06066138
Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Phase 1 · United States · 1 site
Registry update: 16 Oct 2026
NCT07450950
Recruiting
Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant Disease
Not applicable · Denmark · 1 site
Registry update: 5 Mar 2026
NCT07129317
Recruiting
Pediatric Radiation Therapy Registry
Not applicable · United States · 2 sites
Registry update: 5 Nov 2025
NCT07192068
Recruiting
Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
Phase 2 · France · 19 sites
Registry update: 19 Dec 2025
NCT07139990
Recruiting
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
Phase 1 · United States · 1 site
Registry update: 17 Aug 2026
NCT06835049
Recruiting
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
Phase 2 · Switzerland · 8 sites
Registry update: 30 Dec 2025
NCT06957431
Recruiting
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Phase 1 · United States · 1 site
Registry update: 3 Jun 2026
NCT06942442
Recruiting
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Phase 2 · United Kingdom, United States · 4 sites
Registry update: 26 Oct 2026
NCT07276867
Recruiting
Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity
Not applicable · Egypt · 1 site
Registry update: 11 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.